Clinical Experience with Eculizumab in Treatment-Refractory Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis

BACKGROUND: Although established therapies are effective in most patients with generalized myasthenia gravis (gMG), some patients do not respond or they experience intolerable adverse events, highlighting the need for better tolerated, targeted therapies for treatment-refractory gMG. OBJECTIVE: To d...

Descripción completa

Detalles Bibliográficos
Autores principales: Katyal, Nakul, Narula, Naureen, Govindarajan, Raghav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2021
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075396/
https://www.ncbi.nlm.nih.gov/pubmed/33325394
http://dx.doi.org/10.3233/JND-200584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075396/
https://www.ncbi.nlm.nih.gov/pubmed/33325394
http://dx.doi.org/10.3233/JND-200584

Ejemplares similares